3SBio Inc. announced that Kevin Xiao Weihong has joined the company as its new chief operating officer. Mr. Xiao has experience within PRC's pharmaceutical industry. He served as chief executive officer of Hisun Pfizer Pharmaceutical Co.

Ltd. from 2012 to 2015 where he oversaw the strategy and operations of the Hisun and Pfizer joint venture. From 2007 to 2012, Mr. Xiao served as a general manager of Commercial and Diversified Business BU of Pfizer China. Prior to this role Mr. Xiao worked in Pfizer China's human resources department from 1999 to 2007 and served as HR Director of Pfizer China from 2004 to 2007.

He is currently the vice president of the Chinese Pharmaceutical Enterprises Association. After his appointment as chief operating officer, Mr. Xiao will work closely with the management of the company in the day-to-day management of the 3SBio Group and will work under the immediate authority of and report directly to Dr. Jing Lou, Chairman and CEO of the company.